表紙:膣炎治療薬市場:疾患タイプ、薬剤クラス別、投与経路、モード、流通チャネル、世界予測(2023-2032年)
市場調査レポート
商品コード
1392209

膣炎治療薬市場:疾患タイプ、薬剤クラス別、投与経路、モード、流通チャネル、世界予測(2023-2032年)

Vaginitis Therapeutics Market-By Disease Type (Bacterial Vaginosis, Candidiasis), Drug Class (Anti-bacterial, Anti-fungal), Route of Administration (Oral, Topical), Mode (OTC, Prescription), Distribution Channel, Global Forecast (2023-2032)

出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 170 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.49円
膣炎治療薬市場:疾患タイプ、薬剤クラス別、投与経路、モード、流通チャネル、世界予測(2023-2032年)
出版日: 2023年10月30日
発行: Global Market Insights Inc.
ページ情報: 英文 170 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の膣炎治療薬市場は、ライフスタイルの変化、医療費の増加、継続的な医薬品の革新により、2023年から2032年にかけてCAGR 7.6%で成長します。

ライフスタイルの変化は膣感染症の増加をもたらし、効果的な治療薬の需要を促進します。ヘルスケア支出の増加は高度な治療選択肢を促進し、継続的な医薬品イノベーションは多様な患者のニーズに応えます。ライフスタイルの変化、ヘルスケアへの投資、医薬品ソリューションの進歩の間のダイナミックな相互作用に対応し、このような要因の収束は、膣炎治療薬市場を大幅に成長させるでしょう。

例えば、2023年には南京大学の研究者が、カンジダ膣炎の治療のために膣の微小環境を管理するように設計されたプロバイオティクス特性を持つナノザイムヒドロゲルを開発しました。このブレークスルーは、膣微小環境を管理するための効果的なソリューションを導入することで膣炎治療薬市場の見通しを強化し、治療の重要な側面に対処し、市場機会を拡大する可能性があります。

膣炎治療薬市場は、疾患タイプ、投与経路、地域に基づいて分別されます。

膣領域におけるカンジダ関連感染症の広範な発生により、カンジダ症セグメントの業界規模は2032年まで大きな利益を獲得します。膣炎の一般的な形態であるカンジダ症は、標的治療薬に対する高い需要を促しています。効果的で個別化された治療に焦点を当て、市場の軌跡は、膣炎症例への一般的な影響を反映し、疾患タイプセグメント内でカンジダ症が占める大きなシェアによって形成されます。

経口セグメントは著しい成長を示し、2032年までに顕著な膣炎治療薬市場シェアを獲得します。この優位性は、経口薬に関連する利便性と患者の嗜好性に起因しています。医薬品の進歩により経口製剤の改良が進むにつれ、その有効性と使いやすさが、膣炎治療における経口治療薬の需要拡大に寄与しています。患者中心の解決策に焦点を当てることで、経口経路は市場を形成する極めて重要な要因として浮上し、大きなシェアを占めるでしょう。

アジア太平洋の膣炎治療薬産業は、2023年から2032年にかけて顕著なCAGRを記録するでしょう。これは、女性の健康に対する意識の高まり、医療費の増加、同地域における膣炎の有病率の増加といった要因に後押しされています。人口の急増とヘルスケアのインフラ整備が進むアジア太平洋地域は、2032年までに同市場への主要な貢献国になると思われます。効果的な治療薬への需要が高まり続ける中、この地域の貢献は成長軌道を形成し、膣炎治療薬産業における主要シェアを維持するでしょう。

目次

第1章 調査手法と調査範囲

第2章 エグゼクティブサマリー

第3章 膣炎治療薬市場の産業洞察

  • エコシステム分析
  • 業界への影響要因
    • 促進要因
      • 膣感染症の高い有病率
      • 女性の健康に対する意識の高まりと効果的な治療法の利用可能性
      • 医薬品開発の進歩がん患者の増加
    • 業界の潜在的リスク&課題
      • 抗生物質耐性の増加
  • 成長の可能性分析
  • COVID-19影響分析
  • 規制状況
  • ポーター分析
  • PESTEL分析

第4章 競合情勢

  • イントロダクション
  • 企業マトリックス分析
  • 主要市場プレーヤーの競合分析
  • 競合のポジショニングマトリックス
  • 戦略ダッシュボード

第5章 膣炎治療薬市場規模・予測:疾患タイプ別、2018年~2032年

  • 主要動向:疾患タイプ別
  • 細菌性膣炎
  • カンジダ症
  • トリコモナス症
  • その他の疾患タイプ

第6章 膣炎治療薬市場規模・予測:薬剤クラス別、2018年~2032年

  • 主要動向:薬剤クラス別
  • 抗菌薬
  • 抗真菌薬
  • 抗原虫
  • その他の薬剤クラス別

第7章 膣炎治療薬市場規模・予測:投与経路別、2018年~2032年

  • 主要動向:投与経路別
  • 経口
  • 局所

第8章 膣炎治療薬の市場規模・予測:モード別、2018年~2032年

  • 主要動向:モード別
  • 市販薬
  • 処方薬

第9章 膣炎治療薬市場規模・予測:流通チャネル別、2018年~2032年

  • 主要動向:流通チャネル別
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第10章 膣炎治療薬の市場規模・予測:地域別

  • 主要動向:地域別
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • その他中東とアフリカ

第11章 企業プロファイル

  • Pfizer, Inc.
  • Merck & Co.
  • Novartis AG
  • Bayer AG
  • Lupin Pharmaceuticals, Inc.
  • Sanofi SA
  • Dr. Reddy's Laboratories Ltd
  • Sun Pharmaceuticals Pvt Ltd
  • Cipla Ltd
  • Takeda Pharmaceuticals
  • Astellas Pharma
図表

Data Tables

  • TABLE 1 Market revenue, by disease type (2022)
  • TABLE 2 Market revenue, by drug class (2022)
  • TABLE 3 Market revenue, by route of administration (2022)
  • TABLE 4 Market revenue, by mode (2022)
  • TABLE 5 Market revenue, by distribution channel (2022)
  • TABLE 6 Market share, by region (2022)
  • TABLE 7 Global vaginitis therapeutics market size, by region, 2018 - 2022 (USD Million)
  • TABLE 8 Global vaginitis therapeutics market size, by region, 2023 - 2032 (USD Million)
  • TABLE 9 Global vaginitis therapeutics market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 10 Global vaginitis therapeutics market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 11 Global vaginitis therapeutics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 12 Global vaginitis therapeutics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 13 Global vaginitis therapeutics market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 14 Global vaginitis therapeutics market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 15 Global vaginitis therapeutics market size, by mode, 2018 - 2022 (USD Million)
  • TABLE 16 Global vaginitis therapeutics market size, by mode, 2023 - 2032 (USD Million)
  • TABLE 17 Global vaginitis therapeutics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 18 Global vaginitis therapeutics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 19 Industry impact forces
  • TABLE 20 Bacterial vaginosis market size, 2018 - 2022 (USD Million)
  • TABLE 21 Bacterial vaginosis market size, 2023 - 2032 (USD Million)
  • TABLE 22 Candidiasis market size, 2018 - 2022 (USD Million)
  • TABLE 23 Candidiasis market size, 2023 - 2032 (USD Million)
  • TABLE 24 Trichomoniasis market size, 2018 - 2022 (USD Million)
  • TABLE 25 Trichomoniasis market size, 2023 - 2032 (USD Million)
  • TABLE 26 Other disease types market size, 2018 - 2022 (USD Million)
  • TABLE 27 Other disease types market size, 2023 - 2032 (USD Million)
  • TABLE 28 Anti-bacterial market size, 2018 - 2022 (USD Million)
  • TABLE 29 Anti-bacterial market size, 2023 - 2032 (USD Million)
  • TABLE 30 Anti-fungal market size, 2018 - 2022 (USD Million)
  • TABLE 31 Anti-fungal market size, 2023 - 2032 (USD Million)
  • TABLE 32 Anti-protozoal market size, 2018 - 2022 (USD Million)
  • TABLE 33 Anti-protozoal market size, 2023 - 2032 (USD Million)
  • TABLE 34 Other drug classes market size, 2018 - 2022 (USD Million)
  • TABLE 35 Other drug classes market size, 2023 - 2032 (USD Million)
  • TABLE 36 Oral market size, 2018 - 2022 (USD Million)
  • TABLE 37 Oral market size, 2023 - 2032 (USD Million)
  • TABLE 38 Topical market size, 2018 - 2022 (USD Million)
  • TABLE 39 Topical market size, 2023 - 2032 (USD Million)
  • TABLE 40 Over-the-counter market size, 2018 - 2022 (USD Million)
  • TABLE 41 Over-the-counter market size, 2023 - 2032 (USD Million)
  • TABLE 42 Prescription market size, 2018 - 2022 (USD Million)
  • TABLE 43 Prescription market size, 2023 - 2032 (USD Million)
  • TABLE 44 Hospital pharmacy market size, 2018 - 2022 (USD Million)
  • TABLE 45 Hospital pharmacy market size, 2023 - 2032 (USD Million)
  • TABLE 46 Retail pharmacy market size, 2018 - 2022 (USD Million)
  • TABLE 47 Retail pharmacy market size, 2023 - 2032 (USD Million)
  • TABLE 48 Online pharmacy market size, 2018 - 2022 (USD Million)
  • TABLE 49 Online pharmacy market size, 2023 - 2032 (USD Million)
  • TABLE 50 North America Vaginitis therapeutics market size, by country, 2018 - 2022 (USD Million)
  • TABLE 51 North America Vaginitis therapeutics market size, by country, 2023 - 2032 (USD Million)
  • TABLE 52 North America Vaginitis therapeutics market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 53 North America Vaginitis therapeutics market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 54 North America Vaginitis therapeutics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 55 North America Vaginitis therapeutics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 56 North America Vaginitis therapeutics market size, route of administration, 2018 - 2022 (USD Million)
  • TABLE 57 North America Vaginitis therapeutics market size, route of administration, 2023 - 2032 (USD Million)
  • TABLE 58 North America Vaginitis therapeutics market size, mode, 2018 - 2022 (USD Million)
  • TABLE 59 North America Vaginitis therapeutics market size, mode, 2023 - 2032 (USD Million)
  • TABLE 60 North America Vaginitis therapeutics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 61 North America Vaginitis therapeutics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 62 U.S. Vaginitis therapeutics market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 63 U.S. Vaginitis therapeutics market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 64 U.S. Vaginitis therapeutics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 65 U.S. Vaginitis therapeutics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 66 U.S. Vaginitis therapeutics market size, route of administration, 2018 - 2022 (USD Million)
  • TABLE 67 U.S. Vaginitis therapeutics market size, route of administration, 2023 - 2032 (USD Million)
  • TABLE 68 U.S. Vaginitis therapeutics market size, mode, 2018 - 2022 (USD Million)
  • TABLE 69 U.S. Vaginitis therapeutics market size, mode, 2023 - 2032 (USD Million)
  • TABLE 70 U.S. Vaginitis therapeutics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 71 U.S. Vaginitis therapeutics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 72 Canada Vaginitis therapeutics market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 73 Canada Vaginitis therapeutics market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 74 Canada Vaginitis therapeutics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 75 Canada Vaginitis therapeutics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 76 Canada Vaginitis therapeutics market size, route of administration, 2018 - 2022 (USD Million)
  • TABLE 77 Canada Vaginitis therapeutics market size, route of administration, 2023 - 2032 (USD Million)
  • TABLE 78 Canada Vaginitis therapeutics market size, mode, 2018 - 2022 (USD Million)
  • TABLE 79 Canada Vaginitis therapeutics market size, mode, 2023 - 2032 (USD Million)
  • TABLE 80 Canada Vaginitis therapeutics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 81 Canada Vaginitis therapeutics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 82 Europe Vaginitis therapeutics market size, by country, 2018 - 2022 (USD Million)
  • TABLE 83 Europe Vaginitis therapeutics market size, by country, 2023 - 2032 (USD Million)
  • TABLE 84 Europe Vaginitis therapeutics market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 85 Europe Vaginitis therapeutics market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 86 Europe Vaginitis therapeutics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 87 Europe Vaginitis therapeutics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 88 Europe Vaginitis therapeutics market size, route of administration, 2018 - 2022 (USD Million)
  • TABLE 89 Europe Vaginitis therapeutics market size, route of administration, 2023 - 2032 (USD Million)
  • TABLE 90 Europe Vaginitis therapeutics market size, mode, 2018 - 2022 (USD Million)
  • TABLE 91 Europe Vaginitis therapeutics market size, mode, 2023 - 2032 (USD Million)
  • TABLE 92 Europe Vaginitis therapeutics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 93 Europe Vaginitis therapeutics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 94 Germany Vaginitis therapeutics market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 95 Germany Vaginitis therapeutics market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 96 Germany Vaginitis therapeutics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 97 Germany Vaginitis therapeutics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 98 Germany Vaginitis therapeutics market size, route of administration, 2018 - 2022 (USD Million)
  • TABLE 99 Germany Vaginitis therapeutics market size, route of administration, 2023 - 2032 (USD Million)
  • TABLE 100 Germany Vaginitis therapeutics market size, mode, 2018 - 2022 (USD Million)
  • TABLE 101 Germany Vaginitis therapeutics market size, mode, 2023 - 2032 (USD Million)
  • TABLE 102 Germany Vaginitis therapeutics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 103 Germany Vaginitis therapeutics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 104 UK Vaginitis therapeutics market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 105 UK Vaginitis therapeutics market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 106 UK Vaginitis therapeutics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 107 UK Vaginitis therapeutics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 108 UK Vaginitis therapeutics market size, route of administration, 2018 - 2022 (USD Million)
  • TABLE 109 UK Vaginitis therapeutics market size, route of administration, 2023 - 2032 (USD Million)
  • TABLE 110 UK Vaginitis therapeutics market size, mode, 2018 - 2022 (USD Million)
  • TABLE 111 UK Vaginitis therapeutics market size, mode, 2023 - 2032 (USD Million)
  • TABLE 112 UK Vaginitis therapeutics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 113 UK Vaginitis therapeutics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 114 France Vaginitis therapeutics market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 115 France Vaginitis therapeutics market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 116 France Vaginitis therapeutics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 117 France Vaginitis therapeutics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 118 France Vaginitis therapeutics market size, route of administration, 2018 - 2022 (USD Million)
  • TABLE 119 France Vaginitis therapeutics market size, route of administration, 2023 - 2032 (USD Million)
  • TABLE 120 France Vaginitis therapeutics market size, mode, 2018 - 2022 (USD Million)
  • TABLE 121 France Vaginitis therapeutics market size, mode, 2023 - 2032 (USD Million)
  • TABLE 122 France Vaginitis therapeutics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 123 France Vaginitis therapeutics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 124 Spain Vaginitis therapeutics market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 125 Spain Vaginitis therapeutics market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 126 Spain Vaginitis therapeutics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 127 Spain Vaginitis therapeutics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 128 Spain Vaginitis therapeutics market size, route of administration, 2018 - 2022 (USD Million)
  • TABLE 129 Spain Vaginitis therapeutics market size, route of administration, 2023 - 2032 (USD Million)
  • TABLE 130 Spain Vaginitis therapeutics market size, mode, 2018 - 2022 (USD Million)
  • TABLE 131 Spain Vaginitis therapeutics market size, mode, 2023 - 2032 (USD Million)
  • TABLE 132 Spain Vaginitis therapeutics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 133 Spain Vaginitis therapeutics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 134 Italy Vaginitis therapeutics market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 135 Italy Vaginitis therapeutics market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 136 Italy Vaginitis therapeutics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 137 Italy Vaginitis therapeutics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 138 Italy Vaginitis therapeutics market size, route of administration, 2018 - 2022 (USD Million)
  • TABLE 139 Italy Vaginitis therapeutics market size, route of administration, 2023 - 2032 (USD Million)
  • TABLE 140 Italy Vaginitis therapeutics market size, mode, 2018 - 2022 (USD Million)
  • TABLE 141 Italy Vaginitis therapeutics market size, mode, 2023 - 2032 (USD Million)
  • TABLE 142 Italy Vaginitis therapeutics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 143 Italy Vaginitis therapeutics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 144 Rest of Europe Vaginitis therapeutics market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 145 Rest of Europe Vaginitis therapeutics market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 146 Rest of Europe Vaginitis therapeutics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 147 Rest of Europe Vaginitis therapeutics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 148 Rest of Europe Vaginitis therapeutics market size, route of administration, 2018 - 2022 (USD Million)
  • TABLE 149 Rest of Europe Vaginitis therapeutics market size, route of administration, 2023 - 2032 (USD Million)
  • TABLE 150 Rest of Europe Vaginitis therapeutics market size, mode, 2018 - 2022 (USD Million)
  • TABLE 151 Rest of Europe Vaginitis therapeutics market size, mode, 2023 - 2032 (USD Million)
  • TABLE 152 Rest of Europe Vaginitis therapeutics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 153 Rest of Europe Vaginitis therapeutics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 154 Asia Pacific Vaginitis therapeutics market size, by country, 2018 - 2022 (USD Million)
  • TABLE 155 Asia Pacific Vaginitis therapeutics market size, by country, 2023 - 2032 (USD Million)
  • TABLE 156 Asia Pacific Vaginitis therapeutics market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 157 Asia Pacific Vaginitis therapeutics market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 158 Asia Pacific Vaginitis therapeutics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 159 Asia Pacific Vaginitis therapeutics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 160 Asia Pacific Vaginitis therapeutics market size, route of administration, 2018 - 2022 (USD Million)
  • TABLE 161 Asia Pacific Vaginitis therapeutics market size, route of administration, 2023 - 2032 (USD Million)
  • TABLE 162 Asia Pacific Vaginitis therapeutics market size, mode, 2018 - 2022 (USD Million)
  • TABLE 163 Asia Pacific Vaginitis therapeutics market size, mode, 2023 - 2032 (USD Million)
  • TABLE 164 Asia Pacific Vaginitis therapeutics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 165 Asia Pacific Vaginitis therapeutics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 166 China Vaginitis therapeutics market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 167 China Vaginitis therapeutics market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 168 China Vaginitis therapeutics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 169 China Vaginitis therapeutics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 170 China Vaginitis therapeutics market size, route of administration, 2018 - 2022 (USD Million)
  • TABLE 171 China Vaginitis therapeutics market size, route of administration, 2023 - 2032 (USD Million)
  • TABLE 172 China Vaginitis therapeutics market size, mode, 2018 - 2022 (USD Million)
  • TABLE 173 China Vaginitis therapeutics market size, mode, 2023 - 2032 (USD Million)
  • TABLE 174 China Vaginitis therapeutics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 175 China Vaginitis therapeutics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 176 Japan Vaginitis therapeutics market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 177 Japan Vaginitis therapeutics market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 178 Japan Vaginitis therapeutics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 179 Japan Vaginitis therapeutics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 180 Japan Vaginitis therapeutics market size, route of administration, 2018 - 2022 (USD Million)
  • TABLE 181 Japan Vaginitis therapeutics market size, route of administration, 2023 - 2032 (USD Million)
  • TABLE 182 Japan Vaginitis therapeutics market size, mode, 2018 - 2022 (USD Million)
  • TABLE 183 Japan Vaginitis therapeutics market size, mode, 2023 - 2032 (USD Million)
  • TABLE 184 Japan Vaginitis therapeutics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 185 Japan Vaginitis therapeutics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 186 India Vaginitis therapeutics market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 187 India Vaginitis therapeutics market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 188 India Vaginitis therapeutics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 189 India Vaginitis therapeutics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 190 India Vaginitis therapeutics market size, route of administration, 2018 - 2022 (USD Million)
  • TABLE 191 India Vaginitis therapeutics market size, route of administration, 2023 - 2032 (USD Million)
  • TABLE 192 India Vaginitis therapeutics market size, mode, 2018 - 2022 (USD Million)
  • TABLE 193 India Vaginitis therapeutics market size, mode, 2023 - 2032 (USD Million)
  • TABLE 194 India Vaginitis therapeutics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 195 India Vaginitis therapeutics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 196 Australia Vaginitis therapeutics market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 197 Australia Vaginitis therapeutics market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 198 Australia Vaginitis therapeutics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 199 Australia Vaginitis therapeutics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 200 Australia Vaginitis therapeutics market size, route of administration, 2018 - 2022 (USD Million)
  • TABLE 201 Australia Vaginitis therapeutics market size, route of administration, 2023 - 2032 (USD Million)
  • TABLE 202 Australia Vaginitis therapeutics market size, mode, 2018 - 2022 (USD Million)
  • TABLE 203 Australia Vaginitis therapeutics market size, mode, 2023 - 2032 (USD Million)
  • TABLE 204 Australia Vaginitis therapeutics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 205 Australia Vaginitis therapeutics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 206 Rest of Asia Pacific Vaginitis therapeutics market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 207 Rest of Asia Pacific Vaginitis therapeutics market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 208 Rest of Asia Pacific Vaginitis therapeutics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 209 Rest of Asia Pacific Vaginitis therapeutics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 210 Rest of Asia Pacific Vaginitis therapeutics market size, route of administration, 2018 - 2022 (USD Million)
  • TABLE 211 Rest of Asia Pacific Vaginitis therapeutics market size, route of administration, 2023 - 2032 (USD Million)
  • TABLE 212 Rest of Asia Pacific Vaginitis therapeutics market size, mode, 2018 - 2022 (USD Million)
  • TABLE 213 Rest of Asia Pacific Vaginitis therapeutics market size, mode, 2023 - 2032 (USD Million)
  • TABLE 214 Rest of Asia Pacific Vaginitis therapeutics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 215 Rest of Asia Pacific Vaginitis therapeutics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 216 Latin America Vaginitis therapeutics market size, by country, 2018 - 2022 (USD Million)
  • TABLE 217 Latin America Vaginitis therapeutics market size, by country, 2023 - 2032 (USD Million)
  • TABLE 218 Latin America Vaginitis therapeutics market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 219 Latin America Vaginitis therapeutics market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 220 Latin America Vaginitis therapeutics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 221 Latin America Vaginitis therapeutics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 222 Latin America Vaginitis therapeutics market size, route of administration, 2018 - 2022 (USD Million)
  • TABLE 223 Latin America Vaginitis therapeutics market size, route of administration, 2023 - 2032 (USD Million)
  • TABLE 224 Latin America Vaginitis therapeutics market size, mode, 2018 - 2022 (USD Million)
  • TABLE 225 Latin America Vaginitis therapeutics market size, mode, 2023 - 2032 (USD Million)
  • TABLE 226 Latin America Vaginitis therapeutics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 227 Latin America Vaginitis therapeutics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 228 Brazil Vaginitis therapeutics market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 229 Brazil Vaginitis therapeutics market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 230 Brazil Vaginitis therapeutics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 231 Brazil Vaginitis therapeutics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 232 Brazil Vaginitis therapeutics market size, route of administration, 2018 - 2022 (USD Million)
  • TABLE 233 Brazil Vaginitis therapeutics market size, route of administration, 2023 - 2032 (USD Million)
  • TABLE 234 Brazil Vaginitis therapeutics market size, mode, 2018 - 2022 (USD Million)
  • TABLE 235 Brazil Vaginitis therapeutics market size, mode, 2023 - 2032 (USD Million)
  • TABLE 236 Brazil Vaginitis therapeutics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 237 Brazil Vaginitis therapeutics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 238 Mexico Vaginitis therapeutics market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 239 Mexico Vaginitis therapeutics market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 240 Mexico Vaginitis therapeutics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 241 Mexico Vaginitis therapeutics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 242 Mexico Vaginitis therapeutics market size, route of administration, 2018 - 2022 (USD Million)
  • TABLE 243 Mexico Vaginitis therapeutics market size, route of administration, 2023 - 2032 (USD Million)
  • TABLE 244 Mexico Vaginitis therapeutics market size, mode, 2018 - 2022 (USD Million)
  • TABLE 245 Mexico Vaginitis therapeutics market size, mode, 2023 - 2032 (USD Million)
  • TABLE 246 Mexico Vaginitis therapeutics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 247 Mexico Vaginitis therapeutics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 248 Rest of Latin America Vaginitis therapeutics market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 249 Rest of Latin America Vaginitis therapeutics market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 250 Rest of Latin America Vaginitis therapeutics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 251 Rest of Latin America Vaginitis therapeutics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 252 Rest of Latin America Vaginitis therapeutics market size, route of administration, 2018 - 2022 (USD Million)
  • TABLE 253 Rest of Latin America Vaginitis therapeutics market size, route of administration, 2023 - 2032 (USD Million)
  • TABLE 254 Rest of Latin America Vaginitis therapeutics market size, mode, 2018 - 2022 (USD Million)
  • TABLE 255 Rest of Latin America Vaginitis therapeutics market size, mode, 2023 - 2032 (USD Million)
  • TABLE 256 Rest of Latin America Vaginitis therapeutics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 257 Rest of Latin America Vaginitis therapeutics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 258 Middle East & Africa Vaginitis therapeutics market size, by country, 2018 - 2022 (USD Million)
  • TABLE 259 Middle East & Africa Vaginitis therapeutics market size, by country, 2023 - 2032 (USD Million)
  • TABLE 260 Middle East & Africa Vaginitis therapeutics market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 261 Middle East & Africa Vaginitis therapeutics market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 262 Middle East & Africa Vaginitis therapeutics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 263 Middle East & Africa Vaginitis therapeutics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 264 Middle East & Africa Vaginitis therapeutics market size, route of administration, 2018 - 2022 (USD Million)
  • TABLE 265 Middle East & Africa Vaginitis therapeutics market size, route of administration, 2023 - 2032 (USD Million)
  • TABLE 266 Middle East & Africa Vaginitis therapeutics market size, mode, 2018 - 2022 (USD Million)
  • TABLE 267 Middle East & Africa Vaginitis therapeutics market size, mode, 2023 - 2032 (USD Million)
  • TABLE 268 Middle East & Africa Vaginitis therapeutics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 269 Middle East & Africa Vaginitis therapeutics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 270 South Africa Vaginitis therapeutics market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 271 South Africa Vaginitis therapeutics market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 272 South Africa Vaginitis therapeutics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 273 South Africa Vaginitis therapeutics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 274 South Africa Vaginitis therapeutics market size, route of administration, 2018 - 2022 (USD Million)
  • TABLE 275 South Africa Vaginitis therapeutics market size, route of administration, 2023 - 2032 (USD Million)
  • TABLE 276 South Africa Vaginitis therapeutics market size, mode, 2023 - 2032 (USD Million)
  • TABLE 277 South Africa Vaginitis therapeutics market size, mode, 2018 - 2022 (USD Million)
  • TABLE 278 South Africa Vaginitis therapeutics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 279 South Africa Vaginitis therapeutics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 280 Saudi Arabia Vaginitis therapeutics market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 281 Saudi Arabia Vaginitis therapeutics market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 282 Saudi Arabia Vaginitis therapeutics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 283 Saudi Arabia Vaginitis therapeutics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 284 Saudi Arabia Vaginitis therapeutics market size, route of administration, 2018 - 2022 (USD Million)
  • TABLE 285 Saudi Arabia Vaginitis therapeutics market size, route of administration, 2023 - 2032 (USD Million)
  • TABLE 286 Saudi Arabia Vaginitis therapeutics market size, mode, 2018 - 2022 (USD Million)
  • TABLE 287 Saudi Arabia Vaginitis therapeutics market size, mode, 2023 - 2032 (USD Million)
  • TABLE 288 Saudi Arabia Vaginitis therapeutics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 289 Saudi Arabia Vaginitis therapeutics market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 290 Rest of Middle East & Africa Vaginitis therapeutics market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 291 Rest of Middle East & Africa Vaginitis therapeutics market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 292 Rest of Middle East & Africa Vaginitis therapeutics market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 293 Rest of Middle East & Africa Vaginitis therapeutics market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 294 Rest of Middle East & Africa Vaginitis therapeutics market size, route of administration, 2018 - 2022 (USD Million)
  • TABLE 295 Rest of Middle East & Africa Vaginitis therapeutics market size, route of administration, 2023 - 2032 (USD Million)
  • TABLE 296 Rest of Middle East & Africa Vaginitis therapeutics market size, mode, 2018 - 2022 (USD Million)
  • TABLE 297 Rest of Middle East & Africa Vaginitis therapeutics market size, mode, 2023 - 2032 (USD Million)
  • TABLE 298 Rest of Middle East & Africa Vaginitis therapeutics market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 299 Rest of Middle East & Africa Vaginitis therapeutics market size, by distribution channel, 2023 - 2032 (USD Million)

Charts & Figures

  • FIG 1 Industry segmentation
  • FIG 2 Top-down approach
  • FIG 3 Market estimation and forecast methodology
  • FIG 4 Market forecasting methodology
  • FIG 5 Breakdown of primary participants
  • FIG 6 Vaginitis therapeutics industry 360 degree synopsis, 2018 - 2032
  • FIG 7 Growth potential analysis, by disease type
  • FIG 8 Growth potential analysis, by drug class
  • FIG 9 Growth potential analysis, route of administration
  • FIG 10 Growth potential analysis, mode
  • FIG 11 Growth potential analysis, by distribution channel
  • FIG 12 Porter's analysis
  • FIG 13 PESTEL analysis
  • FIG 14 Company matrix analysis, 202
  • FIG 15 Competitive analysis of major market players, 2022
  • FIG 16 Competitive positioning matrix
  • FIG 17 Strategic dashboard Company matrix analysis, 2022
目次
Product Code: 7213

Global Vaginitis Therapeutics Market will grow at 7.6% CAGR from 2023 to 2032 due to lifestyle changes, escalating healthcare expenditure, and continuous pharmaceutical innovations. Evolving lifestyles contribute to increased incidences of vaginal infections, propelling demand for effective therapeutics. Growing healthcare spending fosters advanced treatment options while ongoing pharmaceutical innovations cater to diverse patient needs. This convergence of factors will position the vaginitis therapeutics market for substantial growth, responding to the dynamic interplay between lifestyle shifts, healthcare investment, and advancements in pharmaceutical solutions.

For instance, in 2023, researchers at Nanjing University developed a nanozyme hydrogel with probiotic properties designed to manage the vaginal microenvironment for the treatment of Candida vaginitis. This breakthrough will strengthen the vaginitis therapeutics market outlook by introducing an effective solution for managing the vaginal microenvironment, addressing a crucial aspect of treatment, and potentially expanding market opportunities.

The vaginitis therapeutics market is segregated based on disease type, route of administration, and region.

The industry size from the candidiasis segment will capture significant gains through 2032, driven by the widespread occurrence of Candida-related infections in the vaginal area. Candidiasis, a common form of vaginitis, prompts a high demand for targeted therapeutics. With a focus on effective and tailored treatments, the market's trajectory is shaped by the substantial share held by candidiasis within the disease type segment, reflecting its prevalent impact on vaginitis cases.

The oral segment will exhibit significant growth and garner a noticeable vaginitis therapeutics market share by 2032. This prominence stems from the convenience and patient preference associated with oral medications. As pharmaceutical advancements continue to improve oral formulations, their effectiveness and ease of use contribute to the growing demand for oral therapeutics in treating vaginitis. With a focus on patient-centric solutions, the oral route will emerge as a pivotal factor shaping the market and holding a major share.

Asia-Pacific vaginitis therapeutics industry will register a notable CAGR from 2023 to 2032, fueled by factors such as increasing awareness of women's health, rising healthcare expenditure, and the growing prevalence of vaginitis in the region. With a burgeoning population and advancing healthcare infrastructure, Asia-Pacific will be a key contributor to the market by 2032. As the demand for effective therapeutics continues to rise, the region's contribution will shape the growth trajectory and maintain a major share in the vaginitis therapeutics industry.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast parameters
  • 1.4 COVID-19 impact analysis at global level
  • 1.5 Data validation
  • 1.6 Data Sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Vaginitis therapeutics market 360 degree synopsis, 2018 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Regional trends
    • 2.1.3 Disease type trends
    • 2.1.4 Drug class trends
    • 2.1.5 Route of administration trends
    • 2.1.6 Mode trends
    • 2.1.7 Distribution channel trends

Chapter 3 Vaginitis Therapeutics Market Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 High prevalence of vaginal infections
      • 3.2.1.2 Growing awareness about women's health and the availability of effective treatments
      • 3.2.1.3 Advancements in drug developmentIncreasing cases of cancer
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Growing antibiotic resistance
  • 3.3 Growth potential analysis
    • 3.3.1 By disease type
    • 3.3.2 By drug class
    • 3.3.3 By route of administration
    • 3.3.4 By mode
    • 3.3.5 By distribution channel
  • 3.4 COVID- 19 impact analysis
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix, 2022
  • 4.5 Strategic dashboard, 2022

Chapter 5 Vaginitis Therapeutics Market Size and Forecast, By Disease Type, 2018 - 2032 (USD Million)

  • 5.1 Key trends, by disease type
  • 5.2 Bacterial vaginosis
  • 5.3 Candidiasis
  • 5.4 Trichomoniasis
  • 5.5 Other disease types

Chapter 6 Vaginitis Therapeutics Market Size and Forecast, By Drug Class, 2018 - 2032 (USD Million)

  • 6.1 Key trends, by drug class
  • 6.2 Anti-bacterial
  • 6.3 Anti-fungal
  • 6.4 Anti-protozoal
  • 6.5 Other drug classes

Chapter 7 Vaginitis Therapeutics Market Size and Forecast, By Route of Administration, 2018 - 2032 (USD Million)

  • 7.1 Key trends, by route of administration
  • 7.2 Oral
  • 7.3 Topical

Chapter 8 Vaginitis Therapeutics Market Size and Forecast, By Mode, 2018 - 2032 (USD Million)

  • 8.1 Key trends, by mode
  • 8.2 Over-the-counter
  • 8.3 Prescription

Chapter 9 Vaginitis Therapeutics Market Size and Forecast, By Distribution Channel, 2018 - 2032 (USD Million)

  • 9.1 Key trends, by distribution channel
  • 9.2 Hospital pharmacy
  • 9.3 Retail pharmacy
  • 9.4 Online pharmacy

Chapter 10 Vaginitis Therapeutics Market Size and Forecast, By Region (USD Million)

  • 10.1 Key trends, by region
  • 10.2 North America
    • 10.2.1 U.S.
    • 10.2.2 Canada
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 France
    • 10.3.4 Spain
    • 10.3.5 Italy
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 Rest of Asia Pacific
  • 10.5 Latin America
    • 10.5.1 Brazil
    • 10.5.2 Mexico
    • 10.5.3 Rest of Latin America
  • 10.6 Middle East & Africa
    • 10.6.1 South Africa
    • 10.6.2 Saudi Arabia
    • 10.6.3 Rest of Middle East & Africa

Chapter 11 Company Profiles

  • 11.1 Pfizer, Inc.
  • 11.2 Merck & Co.
  • 11.3 Novartis AG
  • 11.4 Bayer AG
  • 11.5 Lupin Pharmaceuticals, Inc.
  • 11.6 Sanofi SA
  • 11.7 Dr. Reddy's Laboratories Ltd
  • 11.8 Sun Pharmaceuticals Pvt Ltd
  • 11.9 Cipla Ltd
  • 11.10 Takeda Pharmaceuticals
  • 11.11 Astellas Pharma